002020 京新藥業
按盤價 
12.740 +0.990 (+8.426%)
12.740 +0.990 (+8.426%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 7.201 | 11.613 | 13.235 | 13.954 | 17.155 |
| 總資產報酬率 ROA (%) | 4.889 | 8.064 | 9.522 | 10.031 | 11.568 |
| 投入資產回報率 ROIC (%) | 6.220 | 10.130 | 11.708 | 12.392 | 14.788 | 邊際利潤分析 |
| 銷售毛利率 (%) | 51.574 | 50.573 | 53.275 | 55.470 | 60.918 |
| 營業利潤率 (%) | 22.148 | 17.857 | 20.017 | 20.137 | 23.492 |
| 息稅前利潤/營業總收入 (%) | 20.627 | 16.360 | 17.937 | 19.095 | 23.215 |
| 淨利潤/營業總收入 (%) | 18.878 | 15.590 | 17.668 | 17.826 | 20.053 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 86.288 | 89.232 | 92.627 | 89.350 | 68.261 |
| 價值變動淨收益/利潤總額(%) | 0.150 | 6.103 | 5.780 | 7.918 | 25.186 |
| 營業外收支淨額/利潤總額(%) | 0.823 | -0.850 | -0.840 | 0.212 | -0.844 | 償債能力分析 |
| 流動比率 (X) | 1.241 | 1.616 | 1.807 | 2.316 | 2.020 |
| 速動比率 (X) | 0.951 | 1.302 | 1.381 | 1.839 | 1.697 |
| 資產負債率 (%) | 32.821 | 30.631 | 29.753 | 25.169 | 0.306 |
| 帶息債務/全部投入資本 (%) | 9.293 | 6.452 | 6.879 | 5.501 | 8.866 |
| 股東權益/帶息債務 (%) | 916.676 | 1,358.410 | 1,261.677 | 1,641.567 | 981.332 |
| 股東權益/負債合計 (%) | 203.651 | 225.326 | 234.920 | 295.028 | 225.984 |
| 利息保障倍數 (X) | -12.097 | -12.154 | -9.375 | -17.614 | -289.594 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 54.159 | 47.079 | 44.518 | 41.288 | 41.070 |
| 存貨周轉天數 (天) | 116.892 | 129.902 | 147.920 | 137.414 | 129.652 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
